Zobrazeno 1 - 10
of 49
pro vyhledávání: '"59"'
Publikováno v:
Transplantation Proceedings. 52:1950-1952
Objective Thrombocytopenia is a common condition in patients undergoing liver transplantation (LT). Thrombocytopenia is prevalent in early postoperative phase, and it gradually improves after several weeks. Delayed severe thrombocytopenia occurring a
Autor:
Dong Kyu Oh, Dae Kyoung Cho, Jae Berm Park, Jung-Joo Choi, Kwang Woo Lee, Byung Gon Na, S.J. Kim, Sang Hyub Lee, Wontae Cho, Hyejeong Park, Wooseong Huh
Publikováno v:
Transplantation proceedings. 48(3)
Antibody-mediated rejection (AMR) is one of the major causes of poor outcomes in ABO-incompatible kidney transplantation (ABOi KT). Studies investigating AMR risk factors found that anti-ABO titer is a major issue. However, the significance of antibo
Autor:
L. Bisignano, Omar Galdame, Maria Margarita Anders, R. Traverso, Manuel Mendizabal, M. Silva, J. C. Bandi, Silvina Yantorno, O.F. Orozco, Luis Gaite, Adrián Gadano, E. de Santibañes, Valeria Descalzi, Sebastián Marciano, O. Gil
Publikováno v:
Transplantation proceedings. 45(4)
Liver transplantation success is limited by the availability of donors. To overcome this limitation, anti-core-positive donors are increasingly being accepted, but underutilization of this resource still occurs. We performed the current study to dete
Autor:
Tamás Mándli, Z. Máthé, Attila Doros, László Kóbori, Anikó Smudla, János Fazakas, E. Dinya, László Piros, Péter Kanizsai, T.K. Rengeiné
Publikováno v:
Transplantation Proceedings. 52:2988-2995
Bloodless liver transplantations (LT) have already been reported, but special characteristics of hemostatic changes remain less defined. The aim of this study was to evaluate the "inevitable" loss of coagulation factors (CF) in blood product-free LT.
Publikováno v:
Transplantation proceedings. 36(4)
Introduction The use of desmopressin and vasopressors in cadaveric organ donors is considered a risk factor for graft dysfunction following pancreas transplantation by influencing the microcirculation. The aim of this study was to investigate the inf
Autor:
Tomonori Nakazato, Shinji Ogura
Publikováno v:
Transplantation Proceedings. 53:405-407
Elevated plasma fibrinogen is associated with tumor progression and poor outcomes in several cancers. However, no studies have demonstrated the prognostic value of hyperfibrinogenemia in the setting of autologous hematopoietic stem cell transplantati
Autor:
Jignesh Patel, Michele A. Hamilton, Jon A. Kobashigawa, Dael Geft, Michelle M. Kittleson, Evan P. Kransdorf, Gaurang Vaidya, David Chang, Babak Azarbal, Daniel Luthringer, Lawrence S.C. Czer
Publikováno v:
Transplantation proceedings. 53(1)
Background Giant cell myocarditis (GCM) has a poor prognosis without heart transplant, but post-transplant survival is unknown. Purpose To describe the post-transplant survival of patients with GCM at a large transplant center. Methods Seven patients
Autor:
Bénédicte Janbon, Rachel Tetaz, Nicolas Terrier, Stéphane Charara, Thomas Jouve, Paolo Malvezzi, Johan Noble, Hamza Naciri Bennani, Matthieu Roustit, Diane Giovannini, Jean-Jacques Rambeaud, Gaelle Fiard, Isabelle Gomez, Morgane Heitz, Lionel Rostaing
Publikováno v:
Transplantation proceedings. 52(3)
Background The 2 main objectives regarding living kidney transplant are to provide optimal graft function and to ensure the safety of donation. Our study hypothesized that the glomerular filtration rate of a single kidney (skGFR), when transplanted,
Publikováno v:
Transplantation proceedings. 50(10)
Objective There are no specific recommendations for therapeutic plasma exchange (TPE) in children after renal transplantation. The purpose of this study was to report the experience with TPE in a pediatric transplant setting. Materials and Methods 59
Autor:
Sophia Lionaki, N. Antonakopoulos, Smaragdi Marinaki, Chrysanthi Skalioti, John Boletis, Maria Darema, Georgios Zavos
Publikováno v:
Transplantation Proceedings. 47:1705-1710
Background Long-term allograft survival is a major challenge in kidney transplantation. This study sought to estimate the evolution of renal function in patients receiving different immunosuppressive regimens based on everolimus (EVR). Methods Ninety